Today: 14 June 2026

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

IndusInd Bank’s loan slump deepens: Q3 update shows advances down 13% and CASA sliding

IndusInd Bank’s loan slump deepens: Q3 update shows advances down 13% and CASA sliding

IndusInd Bank’s net advances fell 13% year-on-year to 3.18 trillion rupees as of December 31, marking a fourth straight quarterly decline. Deposits dropped 3.8% from a year earlier but rose 1.1% from September; the CASA ratio slipped to 30.3%. The bank’s loan contraction contrasts with double-digit growth at larger rivals. IndusInd is recovering from a $230 million derivatives misaccounting scandal.
6 January 2026
NAB slides nearly 3% as rate-hike chatter hits bank stocks ahead of Australia inflation print

NAB slides nearly 3% as rate-hike chatter hits bank stocks ahead of Australia inflation print

National Australia Bank shares fell 3.0% to A$41.28 on Tuesday, underperforming the market as traders braced for Wednesday’s CPI data. Australia’s benchmark index slipped 0.92%, with financials among the main drags. Investors recalibrated for the risk of the Reserve Bank of Australia keeping rates higher for longer. NAB’s next trading update is set for February 18.
Macquarie shares buck weak ASX as investors eye Qube deadline and May results

Macquarie shares buck weak ASX as investors eye Qube deadline and May results

Macquarie Group shares rose 1.68% to A$206.76 Tuesday, outperforming the S&P/ASX 200, which fell 0.52%. The stock touched a high of A$207.08 as investors watched for updates on its Qube bid, with the exclusivity deadline set for February 1. No new company filings were posted in the past two days. Macquarie last reported a 3% rise in first-half net profit to A$1.66 billion in November.
BlueScope Steel stock jumps 21% on A$30 takeover bid — the next catalyst investors are watching

BlueScope Steel stock jumps 21% on A$30 takeover bid — the next catalyst investors are watching

BlueScope Steel shares jumped 20.6% to A$29.48 after SGH and Steel Dynamics made a non-binding A$30-per-share takeover offer. The proposal, received Dec. 12, is subject to due diligence, exclusivity, and other conditions. BlueScope’s board is reviewing the bid against its own valuation. The company previously rejected lower offers, citing execution risks.
DroneShield stock jumps 18% as ASX:DRO taps Louis Gamarra as chief commercial officer

DroneShield stock jumps 18% as ASX:DRO taps Louis Gamarra as chief commercial officer

DroneShield shares surged 18.1% to A$3.91 in Sydney on Tuesday, with turnover more than doubling to 32 million shares. The company named Louis Gamarra chief commercial officer to lead global sales. The rally lifted the stock 27% above its Dec. 31 close, even as the broader ASX 200 fell 0.5%. Investors await the next earnings update for signs of sustained demand.
6 January 2026
Legend Biotech stock hits a fresh 52-week low as biotech lags — JPMorgan update looms

Legend Biotech stock hits a fresh 52-week low as biotech lags — JPMorgan update looms

Legend Biotech shares dropped 4.7% to $20.49 Monday, hitting a 52-week low and leaving the stock down 55% from its high. The decline comes ahead of the J.P. Morgan Healthcare Conference, where CEO Ying Huang is set to present Jan. 14. Broader biotech stocks also fell, with key ETFs down about 1%. Investors are watching for updates on CARVYKTI, Legend’s CAR-T therapy for multiple myeloma.
5 January 2026
Sanmina stock slides after early pop as manufacturing data, peer moves hit sentiment

Sanmina stock slides after early pop as manufacturing data, peer moves hit sentiment

Sanmina shares fell 5.1% to $151.12 Monday after an early rally above $165 faded, underperforming as Wall Street hit record highs. Electronics manufacturing peers Jabil, Flex, and Celestica also dropped, pressured by weak U.S. manufacturing data and Jabil’s acquisition of Hanley Energy. Investors are awaiting Friday’s U.S. jobs report and Sanmina’s upcoming earnings window.
5 January 2026
Wall Street’s buyback boom: GM, Southwest and Tapestry headline 2026’s share-repurchase trade

Wall Street’s buyback boom: GM, Southwest and Tapestry headline 2026’s share-repurchase trade

General Motors, Southwest Airlines, and Tapestry posted buyback yields above 10% after repurchasing $8.2 billion, $2.75 billion, and $2.8 billion in stock in 2025, MarketBeat reported Monday. S&P 500 companies bought back a record $1.02 trillion of stock in the 12 months through September, according to S&P Dow Jones Indices. Investors are watching if companies can sustain repurchases without hurting investment.
NewAmsterdam Pharma stock slides on insider sale notices — what investors watch next for NAMS

NewAmsterdam Pharma stock slides on insider sale notices — what investors watch next for NAMS

NewAmsterdam Pharma shares fell about 5% to $33.42 in afternoon trading Monday after two insiders filed Form 144 notices for proposed stock sales tied to RSU vesting. CFO M. Ian Somaiya and CSO Johannes Kastelein flagged plans to sell a combined 11,118 shares. The stock touched an intraday low of $32.68. Biotech stocks broadly lagged the market ahead of Friday’s U.S. jobs report.
5 January 2026
Why Xenon Pharmaceuticals stock is down today as JPM Healthcare Conference nears

Why Xenon Pharmaceuticals stock is down today as JPM Healthcare Conference nears

Xenon Pharmaceuticals shares fell 6.5% to $41.60 Monday afternoon, underperforming biotech peers ahead of next week’s J.P. Morgan Healthcare Conference. The stock traded between $45.21 and $41.45 on volume of 787,000 shares. Cantor Fitzgerald raised its price target to $55 despite the drop. Investors await updates on late-stage epilepsy trial timelines and commercialization plans.
Nextpower (NXT) stock slides as solar shares wobble; $90 level and earnings in focus

Nextpower (NXT) stock slides as solar shares wobble; $90 level and earnings in focus

Nextpower shares dropped 3.9% to $89.18 Monday, erasing an early surge and closing $3.60 below Friday’s finish. The move returned the stock to a key technical support zone after last year’s solar rally. Traders are watching for the company’s fiscal Q3 earnings, expected between Jan. 27 and Feb. 2. Broader solar stocks were mixed as investors awaited U.S. economic data for rate clues.
Comstock Resources stock slides as U.S. gas futures drop on warm-weather outlook

Comstock Resources stock slides as U.S. gas futures drop on warm-weather outlook

Comstock Resources shares dropped 4.2% to $22.60 Monday as U.S. natural gas futures fell over 5% on forecasts for above-normal winter temperatures. Other gas-focused producers also declined, with Antero Resources down 3.8% and Range Resources off 1.8%. Traders cited weaker demand signals and are watching the next U.S. gas-storage update. About 2.2 million Comstock shares traded by midafternoon.
1 306 307 308 309 310 590

Stock Market Today

  • XPeng X9 Electric MPV Tops European EV Test, Spotlighting Stock Valuation and Growth
    June 13, 2026, 7:51 PM EDT. XPeng's X9 electric multi-purpose vehicle (MPV) won best-in-class range and charging performance at El Prix 2026, Europe's largest independent real-world electric vehicle (EV) test. The vehicle showed the highest positive deviation from WLTP (Worldwide Harmonised Light Vehicle Test Procedure) range standards and the fastest charging times, boosting XPeng's (NYSE:XPEV) profile in competitive European EV markets. Despite the strong technical showing, XPeng stock trades about 38% below analysts' average target price of $23.23, currently at $14.49. However, Simply Wall St valuation metrics indicate shares are 77.1% overestimated on their fair value model. Investors should monitor how XPeng leverages these results for marketing, partnerships, and expansion in Europe. Short-term sentiment has been weak, with shares down 13.1% in the past month. Risks remain around converting test success into profitable global scaling.

Latest articles

Kraft Heinz Shares Rally for Six Days—Is KHC a Buy Now?

Kraft Heinz Shares Rally for Six Days—Is KHC a Buy Now?

14 June 2026
Kraft Heinz closed up 0.70% at $24.39, outpacing the S&P 500, as investors weighed its 6.6% dividend yield against falling organic sales, lower adjusted earnings, and cautious analyst targets; the next earnings update is seen as the key test for whether $600 million in marketing and R&D can revive growth and support the stock’s rebound.
Go toTop